Fate Therapeutics (FATE) PT Raised to $20 at BMO Capital; 'Enthusiasm for Cell Therapies Probably Justified'
Tweet Send to a Friend
BMO Capital raised its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
